- 2017
-
Press releases - 10.10.2017
Biomedical Research Mobilized Around Thomas Pesquet
Space is an extraordinary laboratory for medicine and medical research on Earth. That is why Inserm and the CNES have been working together for more than a year[1] to accelerate research progress to improve the health of all of us. The presence of Thomas Pesquet, French astronaut from the European Space Agency (ESA), on board the International Space Station (ISS) for 6 months gave rise to many experiments, the preliminary results of which support the researchers’ hypotheses and sometimes even surprise them.
-
Press releases - 06.10.2017
Tuesday, October 10, 2017, is National “Dys” Day (dyslexia, dysphasia, dysorthographia, etc.)
The 11th edition of National “Dys” Day will be held on Tuesday, October 10, 2017. Created by the Fédération Française des DYS, it mobilizes parents who are members of associations together with professionals from across France. The various learning disabilities that begin with “dys”, and which are now better understood by the general public, affect around 6 million people in France [1](METTRE CHIFFRE). An event is held in Paris each year, attended by around 10,000 people. This year, it will take place on Saturday, October 14, 2017, from 9 a.m. to 6 p.m., at Université Paris 8.
-
Press releases - 06.10.2017
Colon cancer: APC protein affects immunity by preventing pre-cancerous inflammation
Adenomatous polyposis coli (APC) is a gene whose mutations are associated with a rare, hereditary form of colorectal cancer known as familial adenomatous polyposis. Research led by scientists at the Institut Pasteur and Inserm have recently demonstrated that mutations to this gene do not only lead to the emergence of colon polyps; they also harm the immune system, leaving it unable to tackle inflammation of the colonic mucosa. This dual impact supports the development of cancer. The finding, published in the journal Cell Reports on October 3rd, 2017, advances scientific knowledge on the development mechanisms of colorectal cancer.
-
What's on? - 06.10.2017
Tuesday, October 10, 2017, is National “Dys” Day (dyslexia, dysphasia, dysorthographia, etc.)
The 11th edition of National “Dys” Day will be held on Tuesday, October 10, 2017. Created by the Fédération Française des DYS, it mobilizes parents who are members of associations together with professionals from across France. The various learning disabilities that begin with “dys”, and which are now better understood by the general public, affect […]
-
News in brief - 03.10.2017
Benefits of Unit-Dose Antibiotic Sale
Between November 2014 and November 2015, a study conducted by Inserm (Unit 912 SESSTIM – Economic and Social Sciences, Health Systems and Medical Informatics), Université Aix-Marseille, IRD, CNRS and the PACA Regional Health Observatory, trialed the unit-dose dispensing of certain antibiotics across four regions in France. Out of 100 volunteer pharmacies, 75 pharmacies were randomly […]
-
Press releases - 02.10.2017
2017 Nobel Prize in Medicine
On Monday, October 2, three Americans, Jeffrey C. Hall, Michael Rosbash and Michael W. Young, were awarded the 2017 Nobel Prize in Physiology or Medicine for their research on the control of circadian rhythms.
-
What's on? - 02.10.2017
2017 Nobel Prize in Medicine
On Monday, October 2, three Americans, Jeffrey C. Hall, Michael Rosbash and Michael W. Young, were awarded the 2017 Nobel Prize in Physiology or Medicine for their research on the control of circadian rhythms. A field which is also being studied by researchers from Inserm: Claude Gronfier, Inserm researcher and chronobiologist, Stem-cell and Brain Research Institute, Lyon Howard Cooper, […]
-
Press releases - 29.09.2017
Prenatal exposure to endocrine disruptors and behavioral problems in children
An epidemiological study carried out by Inserm on families from the EDEN cohort (500 boys born between 2003 and 2006 and their mothers) shows that exposure during pregnancy to certain phenols and phthalates is associated with behavioral problems in boys between 3 and 5 years of age. The most worrying compounds in this respect are bisphenol A, triclosan and dibutyl phthalate (DBP).
-
Press releases - 28.09.2017
How do arteries protect themselves from atherosclerosis?
Associated with an aging population and the development of metabolic syndrome, atherosclerosis is a leading cause of death worldwide. Researchers from Inserm Unit 970, the “Paris Cardiovascular Research Center” (Inserm/Université Paris Descartes), have succeeded in revealing the mechanisms underlying the formation of atherosclerotic plaques. In particular, they have discovered the protective role of autophagy, a mechanism for cleaning and recycling cell components, in the cells that line the inner artery wall. These results, published in PNAS on September 25, 2017, provide us with an improved understanding of the initial stages of plaque development, and open up the possibility of developing a preventive treatment.
-
Press releases - 27.09.2017
The Yin and Yang of Low-dose Irradiation on Hematopoiesis
A team of researchers from CEA, Inserm, and the Paris-Sud and Paris Diderot universities has shown that exposure to low doses of irradiation (0.02 Gy) leads of a loss of hematopoietic stem cell[1] (HSC) function. The team has also shown that irradiation at this low dose facilitates efficient bone marrow transplantation without myeloablation[2]. These results, published in Cell Reports on September 26, 2017, show both the positive and negative aspects of low doses of irradiation.